MetLife Investment Advisors »

Palvella Therapeutics Inc Ne shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $446k 4.3k 104.67
2025-09-30 $267k 4.3k 62.69
2025-06-30 $96k 4.3k 22.54

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Meta Platforms Inc Class A Cl A (META)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Visa Inc Class A Com Cl A (V)
Spdr S&p Etf Trust Tr Unit (SPY)

View all positions for MetLife Investment Advisors

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
State Street Corporation
Perceptive Advisors
Summit Partners Public Asset Management
Jennison Associates
Federated Investors
Woodline Partners
Artisan Partners Limited Partnership
MPM Oncology Impact Management
Caption Management

View all funds holding Palvella Therapeutics Inc Ne